Jay Venkatesan

Jay Venkatesan (senior executive) discloses dealings in 3 companies, chiefly Elicio Therapeutics, Inc., Alpine Immune Sciences, Inc. and Serina Therapeutics, Inc. We count 11 filings; the first trade dates from 9 February 2021 and the latest from 31 March 2026.

Both buying and selling appear: 5 purchases worth €293k, against 1 sale worth €3.2M. On balance, insiders were net sellers of €2.9M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 4 share grants and 1 option exercise.

In size, the median ticket on the buying side is €58k. On 5 out of 5 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

On 21 April 2026 came the latest disclosure, a share grant for €13k in Serina Therapeutics, Inc. The last insider purchase was made public on 27 May 2022, 1,605 days ago. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.